Chemotherapy: still an essential player in non-small-cell lung cancer treatment?

Author： Ferreira Carlos Gil   Montella Tatiane Caldas   Baldotto Clarissa Seródio   Domingues Pedro Masson  

Publisher： Future Medicine

ISSN： 1758-1966

Source： Lung Cancer Management, Vol.2, Iss.5, 2013-10, pp. : 381-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer

By Marinopoulos Spyridon   Skorda Lamprini   Karatapanis Stylianos   Rasidakis Antonis  

Medical Oncology, Vol. 25, Iss. 4, 2008-12 ,pp. : 415-418

Humana Press, Inc

Access to resources Recommend Favorite

Patient versus clinician preferences for chemotherapy in non-small-cell lung cancer

By Long Anne   Ferraro Danielle   Stockler Martin   Blinman Prunella  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 527-536

Future Medicine

Access to resources Recommend Favorite

Erlotinib in the first-line treatment of non-small-cell lung cancer

By D'Arcangelo Manolo   Cappuzzo Federico  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 5, 2013-05 ,pp. : 523-533

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Immune System in the Treatment of Non-Small-Cell Lung Cancer

By Rangachari Deepa   Brahmer Julie  

Current Treatment Options in Oncology, Vol. 14, Iss. 4, 2013-12 ,pp. : 580-594

Springer Publishing Company

Access to resources Recommend Favorite

New oral multitargeted antiangiogenics in non-small-cell lung cancer treatment

By Gori Bruno   Ricciardi Serena   Fulvi Alberto   Del Signore Ester   de Marinis Filippo  

Future Oncology, Vol. 8, Iss. 5, 2012-05 ,pp. : 559-573

Future Medicine

Access to resources Recommend Favorite